Heart Disease Trial, Recruiting NCT06791850 Sponsor: West Virginia University Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06791850
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 50 and 80 years old who have been diagnosed by a doctor with advanced heart failure (a serious condition where the heart cannot pump enough blood, causing significant symptoms even at rest or with minimal activity)
  • Caregivers of patients with advanced heart failure, aged between 45 and 80 years old
  • People who are mentally alert and willing to give their consent to take part in the study
  • People who can read and understand English

Who may not be able to join:

  • People who have already received a heart transplant or a mechanical heart pump (called an LVAD), or who are currently on a waiting list for either of these
  • People who have been diagnosed with a terminal illness or a condition affecting memory and thinking, such as Alzheimer's disease or other forms of dementia

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ubolrat Piamjariyakul, West Virginia University School of Nursing

Phone: 304.293.6729

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
West Virginia University
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
1 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12); Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12); Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12); Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12); Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12); Patient--World Health Organization Quality of life Questionnaire; Patient--World Health Organization Quality of life Questionnaire; Patient--World Health Organization Quality of life Questionnaire; Patient--World Health Organization Quality of life Questionnaire; Patient--World Health Orga...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov